Skip to main content
OpenTrials
Completed

NCT Number: NCT02153411

Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population

Descriptive study on the management of asthma in asthmatic Middle East adult population : Algeria,Egypt, Irak,Iran, Jordan, Koweit, Lebanon, Qatar,Saudi,Tunisia, UAE

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

18 year–130 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Ain Naadja, Nis-rme-xxx-2014/1, Algeria

Loading trial locations.

About this study

Multicentric, transversal, descriptive, epidemiological study, conducted in a random sample of general practitioner and medical specialist (Pulmonologist and/or allergologist) in the public and the private sector.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Men and women, 18 years of age and older. Asthmatic since at least one year before inclusion. Patient's informed consent obtained.

Exclusion criteria

  • Patient concurrently participating to another study. Patient with concomitant pulmonary disease. Patient with psychiatric disorders. Patient consulting for an asthma attack

Treatment and study plan

Primary outcomes

  1. Asthma control

    Time frame: Up to 1 year

    Daytime symptoms Limitation of activities Nocturnal symptoms / awakening Need for reliever /rescue treatment Lung function (PEF or FEV)

Secondary outcomes

  1. general and sociodemographic patient's characteristics

    Time frame: up to 1 year

    sex, age, BMI, educational level, occupation, comorbidities, smoking status, and social security coverage.

  2. Identify predictive factors of asthma control,

    Time frame: UP to 1 year

    such as age, sex, BMI, smoking status, adherence to treatment, asthma history, comorbidity.

  3. asthma control level

    Time frame: Up to 4 weeks

    Asthma control test questionnaire : activities at work,breathless,asthma symptoms (wheezing, coughing, chest tightness, shortness of breath;use of rescue inhaler or taken a nebulizer treatment ,asthma assessment

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Evaluation of aSthma Management in Middle EAst Adult Population

Acronym: ESMAA

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Jun 3, 2014
Registry last updated
Nov 8, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.